Correlation Between Neurocrine Biosciences and Collegium Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Neurocrine Biosciences and Collegium Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurocrine Biosciences and Collegium Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurocrine Biosciences and Collegium Pharmaceutical, you can compare the effects of market volatilities on Neurocrine Biosciences and Collegium Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurocrine Biosciences with a short position of Collegium Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurocrine Biosciences and Collegium Pharmaceutical.
Diversification Opportunities for Neurocrine Biosciences and Collegium Pharmaceutical
-0.15 | Correlation Coefficient |
Good diversification
The 3 months correlation between Neurocrine and Collegium is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Neurocrine Biosciences and Collegium Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Collegium Pharmaceutical and Neurocrine Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurocrine Biosciences are associated (or correlated) with Collegium Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Collegium Pharmaceutical has no effect on the direction of Neurocrine Biosciences i.e., Neurocrine Biosciences and Collegium Pharmaceutical go up and down completely randomly.
Pair Corralation between Neurocrine Biosciences and Collegium Pharmaceutical
Given the investment horizon of 90 days Neurocrine Biosciences is expected to generate 3.22 times less return on investment than Collegium Pharmaceutical. But when comparing it to its historical volatility, Neurocrine Biosciences is 1.28 times less risky than Collegium Pharmaceutical. It trades about 0.01 of its potential returns per unit of risk. Collegium Pharmaceutical is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 2,240 in Collegium Pharmaceutical on August 27, 2024 and sell it today you would earn a total of 756.00 from holding Collegium Pharmaceutical or generate 33.75% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Neurocrine Biosciences vs. Collegium Pharmaceutical
Performance |
| Timeline |
| Neurocrine Biosciences |
| Collegium Pharmaceutical |
Neurocrine Biosciences and Collegium Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Neurocrine Biosciences and Collegium Pharmaceutical
The main advantage of trading using opposite Neurocrine Biosciences and Collegium Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurocrine Biosciences position performs unexpectedly, Collegium Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Collegium Pharmaceutical will offset losses from the drop in Collegium Pharmaceutical's long position.| Neurocrine Biosciences vs. Amphastar P | Neurocrine Biosciences vs. Collegium Pharmaceutical | Neurocrine Biosciences vs. Ironwood Pharmaceuticals | Neurocrine Biosciences vs. ANI Pharmaceuticals |
| Collegium Pharmaceutical vs. Phibro Animal Health | Collegium Pharmaceutical vs. ANI Pharmaceuticals | Collegium Pharmaceutical vs. Procaps Group SA | Collegium Pharmaceutical vs. Amphastar P |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |